Study biomarkers to predict outcomes in idiopathic intracranial hypertension
Part of Brain & nervous system clinical trials.
This study looks at body measurements (“biomarkers”) to help doctors diagnose idiopathic intracranial hypertension (IIH) and predict how it may go over time. If you’re an adult with a doctor’s concern for IIH, you may be asked to provide health information and possibly samples for testing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can understand the study and agree to sign informed consent
- You are older than 18 years
- A neurologist or eye doctor has evaluated you and suspects IIH
- You are able to communicate in a way that lets you participate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how body weight (BMI) affects how well people with Idiopathic Intracranial Hypertension (IIH) respond to treatment. It may help doctors understand if weight influences symptom relief.
This trial tests whether placing a small tube (stent) in a narrowed brain vein can help people with newly diagnosed intracranial hypertension (high pressure in the head) that causes vision problems. It is for those who have not yet taken standard medication and have specific vein narrowing seen on MRI.
This study uses advanced brain scans (MRIs) to look at the veins in your brain to help plan a stenting procedure for patients with Idiopathic Intracranial Hypertension (IIH) that is not improving with standard care.
This Phase 3 trial compares putting in a venous sinus stent versus using medicine alone for idiopathic intracranial hypertension (IIH). It aims to see which approach better protects vision and lowers pressure in the brain.
This study uses eye scans to see if changes in the retina can help doctors measure pressure inside the skull. It may help find a safer way to check for high pressure in the brain without needing a needle in the back.
This trial tests an IV treatment called eptinezumab to see if it reduces chronic headaches in people with increased pressure around the brain (IIH). It may help if you have many headache days and meet the other criteria.
Hear when a new Benign Intracranial Hypertension trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.